TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Opioids Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Surging Chronic Pain Incidence

4.1.2 Increasing Geriatric Population

4.2 Market Restraints

4.2.1 Increasing Drug Abuse

4.3 Market Opportunities

4.3.1 Strategic Initiatives by Market Players

4.4 Impact of Drivers and Restraints:

5. Opioids Market - Europe Analysis

5.1 Europe Opioids Market Overview

5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030

5.3 Europe Opioids Market Forecast Analysis

6. Europe Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid

6.1.1 Overview

6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

6.2 Extended Release Long-Acting Opioid

6.2.1 Overview

6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. Europe Opioids Market Analysis - by Application

7.1 Pain Management

7.1.1 Overview

7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Anesthesia

7.2.1 Overview

7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Diarrhea Suppression

7.3.1 Overview

7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cough Suppression

7.4.1 Overview

7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.5 De-Addiction

7.5.1 Overview

7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Opioids Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Transdermal Patch

8.3.1 Overview

8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Opioids Market - Country Analysis

10.1 Europe

10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country

10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product

10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application

10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration

10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel

10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product

10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application

10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration

10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel

10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product

10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application

10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration

10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product

10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application

10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration

10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel

10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product

10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application

10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration

10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel

10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product

10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application

10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration

10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Opioids Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Endo International plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Mallinckrodt Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Neuraxpharm Pharmaceuticals SL

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Hikma Pharmaceuticals Plc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Rusan Pharma Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Teva Pharmaceutical Industries Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Opioids Market Segmentation

Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 46. Recent Organic Growth Strategies in Opioids Market

Table 47. Recent Inorganic Growth Strategies in the Opioids Market

Table 48. Glossary of Terms, Opioids Market

List of Figures

Figure 1. Europe Opioids Market Segmentation, by Country

Figure 2. Europe Opioids Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030

Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)

Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)

Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)

Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)

Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 30. Growth Strategies in Opioids Market